Navigation Links
Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR

s of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Kosan's proprietary formulation of tanespimycin (KOS-953) is currently in Phase 1 and 2 clinical trials, primarily for multiple myeloma in combination with Velcade(R) (bortezomib) and HER2-positive metastatic breast cancer in combination with Herceptin(R) (trastuzumab). In addition, intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), are being evaluated in Phase 1 clinical trials.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's epothilone program is partnered with Roche through a global development and commercialization agreement.

For additional information on Kosan Biosciences, please visit the company's website at www.kosan.com.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 (the "Act"). Such forward-looking statements include but are not limited to statements relating to the further development and potential safety, efficacy and commercialization of Kosan's product candidates; and initiations of pre-clinical and clinical studies and the timing thereof. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference

Post Your Comments:
(Date:11/6/2009)...RNewswire-FirstCall/ -- Virtual Health Technologie... that the previously confirmed Letter of Intent to...gement Technologies, Inc (WNDM) is subject to fina...ders of VHGI. ,, Shareholder Assurances ,...royalty stream and cash realized from the transact...
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...wire/ -- California American Water has designated ... Drain" week for its San Diego County service area...c and private agencies alike toward the common mis...ource water supplies. ,, California American Wa... drop off expired or unwanted pharmaceuticals free...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2New oral agents may prevent injury after radiation exposure 51333 1New oral agents may prevent injury after radiation exposure 51333 2University of Hawaii at Manoa professor published in science journal 9207 1A complete view of complexity in science and society in a new authoritative reference work 9205 1A complete view of complexity in science and society in a new authoritative reference work 9205 2
...007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today a...d improvements in patient-centered outcomes in,pat...ain treated,with the investigational drug Zenvia(T...d in two scientific posters at the,Second Internat...Berlin, Germany on June 7 to 10, 2007., Both poste...
...Results of a Phase 2a,clinical trial evaluating th...t hospital acquired gram-negative bacterial,pneumo...iety (ATS),International Conference, May 18 - 23, ... Niederman, MD, Chairman, Department of, ... of, Medicine; Vice Chairman, Department...
Other Medicine Technology:AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at Second International Congress on,Neuropathic Pain 4Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 2Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be,Presented at American Thoracic Society International Conference 3
(Date:11/7/2009)...A. Cook (GA), Louis J. Goodman (TX), Palmer P. Jon...GO, Nov. 7 The American...dical society executive leaders with achievement a...d ideals of the medical profession. The awards wer... meeting in Houston. ,, (Logo: http://www.ne...
(Date:11/7/2009)...ewswire/ -- With the final House vote on healthcar...g the entire bill hostage to further their antiabo...far beyond the status quo restrictions on abortion.... In an outrageous amendment, which is expected t... Democrats are demanding explicit and unequivocal ...
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi and Democratic le...lowing a Democratic Whip meeting with President Ob...ker,s opening remarks: ,, "Thank you very much...o receive the President of the United States on th...e and making progress for the American people. ,...
(Date:11/7/2009)...ill rebel, expert says , , SATURDAY, Nov. ...ave badly if their parents expect them to, a new U...re simply being realistic might actually contribut..., a psychology professor at Wake Forest University...news release. "Negative expectations on the part o...
(Date:11/7/2009)...economic climate, many Americans are monitoring th...y on what that they consider to be absolutely esse...elieves that it’s very important for overwei...o improve their health, and he is trying to make w...tough economy by offering reasonable prices and mu...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3
... a stubborn myth, researchers at Johns Hopkins hav...nd other cerebrovascular diseases can safely// und...that many doctors have long shunned over concerns ...at not a single patient suffered complications dur...
...ins researchers have teased out the function of a ...rare cognitive disorder associated with overly soc...ed TFII-I, or TF “two eye,” the protein long known...study will be published this week in Science. ...
...y sufferers, the fall season can be just as bad as...ver-the-counter (OTC) medicine; however, can quick...ndividuals are faced with shelf after shelf of pro...t University of the Sciences in Philadelphia. “A l...
...and Fertiliser Minister Ram Vilas Paswan promises ...ee medicines, health insurance and subsidised trea...By Jan 1 we hope to have drug banks operational at...of the drug manufacturers who have agreed to provi...
... year, a National Academy of Sciences (NAS) panel ...ects of perchlorate, an inorganic anion and compon...s ability to absorb iodine from the bloodstream, b...archers at the Centers for Disease Control and Pre...
...hildren succumbing to dengue, the death toll from ... Pradesh.// 'A six-year-old child from Sitap...ward of King George's Medical University on Friday...mber of dengue cases has shot up to 199 in the sta...
Other Medicine News:Health News:Child-Proof: Brain Mapping Safer for Children than Previously Thought 2Health News:Child-Proof: Brain Mapping Safer for Children than Previously Thought 3Health News:Researchers Uncover Critical Player in Cell Communication 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 2Health News:Allergy OTC Medicines–Speak With Your Pharmacis 3Health News:Free Medicines, Health Insurance for Poor Soon: Paswan 2Health News:New Study Suggests Perchlorate Effects on Thyroid Function of U.S. Women 2
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: